Performance of Inherited Risk Assessment for Predicting Prostate Cancer From Prostate Biopsy

The trial is to observe whether inherited risk, including rare pathogenic mutations (RPMs) in several major genes and SNPs-based genetic risk scores (GRS), is correlated with prostate cancer detection rate from diagnostic prostate biopsy.